payload design

Affinia Therapeutics is a gene therapy company developing adeno-associated virus (AAV) gene therapies for rare and prevalent diseases, starting with diseases of the heart and nervous system. Its proprietary ART (Affinia Rationally-designed Therapies) platform uses AI and structural modeling to rationally design novel AAV capsids and therapeutic payloads. Its first program, AFTX-201, targets BAG3-associated dilated cardiomyopathy (DCM).

AAV-gene therapyAI and structural modelingcapsid engineeringgene editinggene replacementgene therapy manufacturingknockdownvectorized antibody

Artel is a carrier-agnostic network systems integrator based in the U.S. that provides secure network communication services to Federal Government agencies. Since 1986, Artel has delivered satellite and terrestrial network communications, systems integration, cyber security, risk management, and IT solutions. It is an ISO 9001:2015 certified network systems integrator.

Cyber securityIT Solutionsnetwork designoperations and maintenancerisk managementsatellite bandwidth managementSystems EngineeringSystems IntegrationTest & Evaluation

Exobiosphere uses microgravity as a new dimension for biology to accelerate drug discovery and unlock therapies that are hard or impossible to develop on Earth. It is building a standardized space-based high-throughput testing platform, the Orbital High-Throughput Screening in Microgravity (OHTS) system, allowing pharma and biotech partners to run automated experiments in orbit at scale, combining microgravity with lab automation and bioinformatics.

Bioinformaticsdata analysishigh throughput screeninglab automationmicrogravity-based disease modelingspace systems engineering